The potential clinical implications of targeted therapies for DLBCL and why the situation is complex
Why has the biobank project been a success and what is the future for it?
Regis Peffault de Latour
New initiatives in the treatment of myeloma
Novel therapies for the treatment of CLL, MCL and FL
Nathan Hale Fowler
Acalabrutinib for the treatment of Richter's transformation and patients with ibrutinib intolerance